Medical Economics

Tariffs aren't just a global issue — they hit your bottom line. With new Trump administration tariffs roiling supply chains and raising costs, physician practices must act now. From assessing vendor risk to revising supplier contracts, this article outlines a proactive plan to protect operations and ensure care continuity. Read more: https://hubs.li/Q03gpCdc0 #MedicalEconomics #Tariffs #BusinessOfMedicine #HealthPolicy

Obesity is not a moral failure — it's a complex, chronic disease. At American College of Physicians #IM2025, experts urged physicians to leave outdated metrics and stigmas behind. Reed Tuckson, MD, FACP, and Mara Gordon, MD, challenge the reliance on BMI and call for care grounded in trust, equity and science. Read how systemic bias, insurance gaps and misinformation are undermining care — and what needs to change: https://hubs.li/Q03gptJg0

Claim denials are crushing health care professionals and their patients. In our latest episode of Off the Chart: A Business of Medicine Podcast, Neal K. Shah breaks down the denied claims problem — and how his work with Counterforce Health uses AI to fix it. 🎧 Listen to the full episode: https://hubs.li/Q03gp7sY0 Apple: https://hubs.li/Q03gnY930 Spotify: https://hubs.li/Q03gp8Nm0 CareYaya Health Technologies #MedicalEconomics #ClaimDenials #AI #HealthcareInnovation

When health insurance companies deny claims, what's happening behind the scenes? Just dropped an incredible podcast with Medical Economics and Physicians Practice, the premier resources trusted by thousands of independent physicians nationwide! Their platform reaches more doctors making critical practice decisions than almost any other medical publication in America. We discussed the shocking reality that over 90% of denied claims are NEVER appealed - leaving massive revenue uncollected and creating headaches for both doctors and patients. 💔 What else? • Neurologists face denial rates approaching 20%, totally wasting time and leaving them unable to care for patients, especially vulnerable older adults • The average cost to manually appeal is $43.84, forcing physicians practices to lose money and time • Providers spend 12-15 hours weekly fighting denials (no one went to Med School to be an insurance negotiator!) Insurance companies have totally weaponized AI for programmatic denials, creating what I called "asymmetric warfare" against providers. On a positive note, I shared how our AI tools at Counterforce Health are generating industry-leading quality of appeals. Even demo'd our voice AI assistant Maxwell that can handle annoying phone calls with insurers. 🤣 I would LOVE for a shout-out on a health insurers' earnings call this year that has to take over $100 million of losses from what Counterforce Health is doing to help patients get the the care they need! 👊 Until regulators wake up and do something, the only hope is through grassroots innovation and absolutely embarrassing these health insurance companies for what they're doing to patients and doctors. Thanks Chris Mazzolini for the amazing opportunity to share the message with your huge audience!! Listen to the full episode to hear my 3 recommendations for policymakers on fixing the broken denial system. What's your most frustrating health insurance experience?

Medical Economics editor Austin Littrell is on the ground in New Orleans covering the 2025 American College of Physicians conference, focusing on the important issues facing the internal medicine profession, like this one:

Looking to learn more about vasomotor symptoms (VMS) and menopause? Our latest Primary View series provides you with tools to enhance your practice. Join us for new insights and safety considerations regarding VMS care. Learn about safety considerations and practical guidance supported by the most current clinical data. In this series, experts and primary care providers cover key topics like hormone therapy alternatives and the prevalence and impact of VMS, equipping you with the knowledge to treat your patients effectively and help them manage their menopausal symptoms. #VMScare #menopause https://hubs.li/Q03f_VJQ0

It takes everyone to achieve health equity. At American College of Physicians #IM2025, Jamar Slocum, MD, MBA, MPH, FACP, Kevin Fiori Jr., MD, MPH, MS, and Earl Stewart, Jr., MD, FACP, led a powerful panel on high-value care strategies to advance health equity. Advancing health equity isn't just the right thing to do — it's financially sound and critical for patient outcomes. Don't miss our coverage: https://hubs.li/Q03f_PNw0 #MedicalEconomics #HealthEquity #ACP #SDOH #HealthPolicy

Policy shifts under the Trump administration are reshaping health care, with potential risks to public health, physician reimbursement and regulatory stability. At the American College of Physicians #IM2025, Shari Erickson, MPH, Brian Outland, PhD, and George Lyons, JD-MBA, led a crucial discussion on the implications of over 100 executive orders, federal workforce cuts and restructuring at HHS, FDA, CDC and CMS. ACP urges physicians to engage in advocacy efforts as health care faces mounting disruptions. Read our full recap: https://hubs.li/Q03f_p8N0 #MedicalEconomics #HealthPolicy #ACP #PhysicianAdvocacy

Check out our interview with Omid Veiseh about the clinician-led biotech innovation they are cooking up at Rice Biotech Launch Pad: https://lnkd.in/ezrvntRJ

Clinician-led innovation is transforming biotech. Omid Veiseh , PhD, faculty director of the Rice Biotech Launch Pad, discusses how his team is bridging the gap between research and real-world medical solutions. 🔹 From immunotherapies to regenerative medicine, see how Rice is driving biotech breakthroughs. 🔹 Why clinician-founded projects are key to solving unmet patient needs. 🔹 The future of medical innovation & tech transfer. Watch the full interview: https://hubs.li/Q03fKTLQ0 #MedicalEconomics #MedTech #MedicalInnovation #Biotech